Value
4.0/10data confidence 100%| Component | Sub-score |
|---|---|
| P/E | 3.7 |
| P/S | 5.7 |
| EV/EBITDA | 0.0 |
| Fwd P/E | 4.7 |
| PEG | 5.1 |
| Analyst target | 4.0 |
- ▸Forward P/E: 26.3x
- ▸PEG: 1.49
Updated
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Agilent is a wide-moat, high-quality diagnostics and research business with strong margins and a 9/9 Piotroski score, but the stock is trading above the analyst target with weak momentum and negative reward-to-risk, limiting near-term upside.
Falsifiable statement — pillar-level invalidators below. Engine-derived; not personalized advice.
| Pillar | Expectation | Trend |
|---|---|---|
Agilent is a high-quality business with a wide economic moat, strong margins around 20%, and a 9/9 Piotroski F-Score that supports durable returns. Quality breakdown | Margins and moat-driven returns should hold, keeping quality score above 7 over the next 12 months. | →Stable |
| CounterEarnings quality warning shows only 74% FCF/NI, suggesting reported profits may not fully convert to cash. | ||
Growth scores are modest (revenue growth 4.5, earnings growth 3.7 out of 10) against a forward P/E of 26.0x and PEG of 1.48, so valuation leaves little margin of safety. Valuation breakdown | Earnings growth should accelerate enough to bring PEG toward or below 1.3 over 12 months. | →Stable |
| CounterHealthcare sector tailwinds and a quality premium may sustain a 26x multiple even with modest growth. | ||
The stock has moved above the analyst target of $163.85 (upside_pct -6.3%), leaving limited upside and negative reward-to-risk of -0.95 at the current price of $174.87. Warnings | Analyst targets should be revised up toward the current price, or price consolidates, within 12 months. | ↓Deteriorating |
| CounterWide-moat compounders often justify premium valuations and targets lag price, so analysts may simply raise targets. | ||
Momentum score is 4.3/10 with falling OBV (volume distribution) even though the stock sits only 4.4% from its 52-week high and above the 200-day MA. Momentum breakdown | Momentum score should recover above 4.5 with OBV turning positive if the uptrend is intact. | ↓Deteriorating |
| CounterPrice remains above the 200-day moving average with a 52-week position score of 9.1, so the long-term trend is still constructive. | ||
Insider activity is minimal, with only one sale totaling $95,972 (0.000% of market cap), so insider selling is not a meaningful negative. Insider breakdown | Insider selling should remain below 0.1% of market cap with no cluster of sales. | →Stable |
| CounterZero insider buying over 90 days and a BEARISH signal show insiders are not adding conviction. | ||
CounterEarnings quality warning shows only 74% FCF/NI, suggesting reported profits may not fully convert to cash.
CounterHealthcare sector tailwinds and a quality premium may sustain a 26x multiple even with modest growth.
CounterWide-moat compounders often justify premium valuations and targets lag price, so analysts may simply raise targets.
CounterPrice remains above the 200-day moving average with a 52-week position score of 9.1, so the long-term trend is still constructive.
CounterZero insider buying over 90 days and a BEARISH signal show insiders are not adding conviction.
| Component | Sub-score |
|---|---|
| P/E | 3.7 |
| P/S | 5.7 |
| EV/EBITDA | 0.0 |
| Fwd P/E | 4.7 |
| PEG | 5.1 |
| Analyst target | 4.0 |
| Component | Sub-score |
|---|---|
| ROE | 7.0 |
| ROA | 5.8 |
| Gross margin | 6.7 |
| Op margin | 10.0 |
| Net margin | 9.8 |
| Current ratio | 7.1 |
| FCF quality | 5.6 |
| Moat | 7.6 |
| Piotroski F | 10.0 |
| Component | Sub-score |
|---|---|
| Rev growth | 4.5 |
| EPS growth | 3.7 |
| Component | Sub-score |
|---|---|
| RSI | 5.5 |
| MACD | 0.0 |
| OBV | 1.0 |
| MA position | 6.0 |
| Volume | 5.4 |
| Component | Sub-score |
|---|---|
| LLM sentiment | 5.0 |
| Analyst rating | 7.5 |
| Price target | 5.9 |
| Component | Sub-score |
|---|---|
| materiality | 5.0 |
| holder change | 4.0 |
| notable moves | 3.0 |
| Component | Sub-score |
|---|---|
| value rank | 5.5 |
| quality rank | 7.8 |
| growth rank | 3.8 |
| Component | Sub-score |
|---|---|
| bollinger | 7.1 |
| support resistance | 7.8 |
| 52w position | 8.8 |
| Component | Sub-score |
|---|---|
| short interest | 9.0 |
| days to cover | 8.9 |
| volatility | 4.2 |
| put call | 10.0 |
| implied vol | 5.5 |
| max pain risk | 3.0 |
| beta | 6.1 |
| debt equity | 7.6 |
| Component | Sub-score |
|---|---|
| erm | 5.0 |
| earnings history | 6.7 |
| earnings timing | 5.0 |
| surprise avg | 4.3 |
| dividend safety | 6.8 |
| news activity | 5.0 |
Maintain position. Not compelling to add more.
L4:PATH_F_HOLD|L3:NEWS_MOD_NO_UPSIDESetup— — No clear chart pattern; technical signals are mixed
EdgeTemporary headwind — High quality (7.7) with weak momentum (3.6)
SuitabilityModerate — Balanced profile
None of the engine's positive-conviction paths (C-quality, D-momentum) triggered — the F-path HOLD reflects balanced signals. Strongest-cleared gate: INSIDER:OK. Top dim: Technical at 7.9; weakest: Momentum at 3.6. No conviction either direction.
The strongest dimensions are Technical at 7.9, Quality at 7.7, and Risk (lower is worse) at 6.8; the weakest are Momentum at 3.6, Insider at 4.0, and Value at 4.0. The V9 engine flagged 2 failed gates with 1 warning, producing an asymmetric reward-to-risk of -0.70 and an engine sizing output of AVOID.
Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.
Trip ifQuality score falls below 7.0 from current 7.7.
Trip ifReward-to-risk ratio stays below -1.5 as price rises more than 15% above the analyst target.
Trip ifMomentum score falls below 3.0 from current 4.3.
Trip ifPEG ratio exceeds 2.0 from current 1.48.
Trip ifInsider selling exceeds 0.1% of market cap in 90 days.